Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrest Nicholson Regulatory News (CRST)

Share Price Information for Crest Nicholson (CRST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 240.20
Bid: 240.20
Ask: 240.80
Change: 2.20 (0.92%)
Spread: 0.60 (0.25%)
Open: 240.00
High: 241.00
Low: 237.80
Prev. Close: 238.00
CRST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - Crest Nicholson Holdings plc

21 Jun 2024 10:24

RNS Number : 4113T
Numis Securities Limited
21 June 2024
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Numis Securities Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Crest Nicholson Holdings plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Deutsche Numis is acting as financial adviser and corporate broker to Bellway plc in relation to the announced non-binding all-share possible offering for Crest Nicolson Holdings plc.

(d) Date dealing undertaken:

20/06/2024

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received (GBX)

Lowest price per unit paid/received (GBX)

5p ordinary

Purchases

 14,233

 244.0000

 240.0000

5p ordinary

Sale

 24,163

 243.0000

 240.3000

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

Date of disclosure:

21/06/2024

Contact name:

Hiten Patel

Telephone number:

+44 121 615 7165

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERPPUCPQUPCUBG
Date   Source Headline
18th Oct 20219:00 amRNSBlock listing Interim Review
27th Jul 202112:00 pmRNSDirectorate Change
29th Jun 20214:16 pmRNSDirector/PDMR Shareholding
24th Jun 20217:00 amRNSHalf-year Report
28th May 20215:25 pmRNSHolding(s) in Company
14th May 20217:00 amRNSDisposal
10th May 20211:00 pmRNSHolding(s) in Company
4th May 20211:03 pmRNSDirectorate Change
19th Apr 20212:31 pmRNSBlock listing Interim Review
23rd Mar 20214:26 pmRNSResult of AGM
23rd Mar 20217:00 amRNSAGM Statement
15th Mar 20219:27 amRNSHolding(s) in Company
5th Mar 20211:56 pmRNSHolding(s) in Company
4th Mar 20214:17 pmRNSHolding(s) in Company
25th Feb 20215:14 pmRNSHolding(s) in Company
16th Feb 20217:00 amRNSAnnual Integrated Report and Notice of AGM
10th Feb 20211:52 pmRNSDirector/PDMR Shareholding
26th Jan 20217:00 amRNSFinal Results
21st Jan 20215:14 pmRNSHolding(s) in Company
24th Nov 20203:18 pmRNSHolding(s) in Company
3rd Nov 20207:00 amRNSTrading Statement
19th Oct 20209:00 amRNSBlock listing Interim Review
23rd Sep 20204:49 pmRNSDirector/PDMR Shareholding
23rd Sep 202012:32 pmRNSDirector/PDMR Shareholding
22nd Sep 20209:16 amRNSDirector/PDMR Shareholding
22nd Sep 20209:14 amRNSDirector/PDMR Shareholding
21st Sep 202012:48 pmRNSHolding(s) in Company
11th Aug 20207:00 amRNSDirector/PDMR Shareholding
7th Aug 20201:51 pmRNSHolding(s) in Company
5th Aug 202012:43 pmRNSHolding(s) in Company
5th Aug 202011:19 amRNSDirector/PDMR Shareholding
24th Jul 20208:00 amRNSDirector/PDMR Shareholding
6th Jul 20202:54 pmRNSDirector/PDMR Shareholding
3rd Jul 20201:03 pmRNSDirector/PDMR Shareholding
3rd Jul 202010:36 amRNSDirector/PDMR Shareholding
29th Jun 202010:31 amRNSDirector Declaration
26th Jun 202011:48 amRNSDirector/PDMR Shareholding
26th Jun 202011:34 amRNSDirector/PDMR Shareholding
26th Jun 202011:34 amRNSDirector/PDMR Shareholding
26th Jun 202010:18 amRNSDirector/PDMR Shareholding
26th Jun 202010:15 amRNSDirector/PDMR Shareholding
24th Jun 20207:00 amRNSHalf-year Report
19th Jun 202011:49 amRNSHolding(s) in Company
18th Jun 20201:29 pmRNSCovid Corporate Finance Facility
5th Jun 20204:33 pmRNSHolding(s) in Company
3rd Jun 20203:29 pmRNSHolding(s) in Company
1st Jun 20203:12 pmRNSHolding(s) in Company
20th May 20207:00 amRNSHolding(s) in Company
13th May 20207:00 amRNSCOVID-19 Update
1st May 20201:38 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.